Top 10 Anti Rabies Vaccine For Human Manufacturers

June 16, 2024

The anti-rabies vaccine for humans is a crucial product in the healthcare market, especially in regions where rabies is prevalent. With increasing awareness about the importance of vaccination, the demand for this vaccine is on the rise. Pharmaceutical companies are constantly innovating to improve the efficacy and accessibility of the vaccine, making it more widely available to consumers. The market for anti-rabies vaccines for humans is expected to grow steadily in the coming years.

Cadila Healthcare
Changchun Zhuoyi Biological Co., Ltd
Novartis
GlaxoSmithKline
Bharat Biotech

Cadila Healthcare

Establishment time : Cadila Healthcare was founded in 1952.

website : www.cadilapharma.com

Main Product : Cadila Healthcare's main products include pharmaceuticals and healthcare products.

Company Profile

Cadila Healthcare is a well-established company in the healthcare sector.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Novartis

Establishment time : 1996

website : www.novartis.com

Main Product : Pharmaceuticals, generics, eye care, and more

Company Profile

Novartis is a multinational pharmaceutical company headquartered in Switzerland, known for its innovative medicines and commitment to improving global health.

GlaxoSmithKline

Establishment time : GlaxoSmithKline, commonly known as GSK, is a British multinational pharmaceutical company.

website :

Main Product : GSK is one of the largest pharmaceutical companies in the world, with a diverse portfolio of products.

Company Profile

Despite these challenges, GSK remains a key player in the pharmaceutical industry, with a commitment to innovation and improving patient outcomes.

Bharat Biotech

Establishment time : Bharat Biotech is a pioneering biotechnology company that specializes in developing innovative vaccines.

website :

Main Product : The company is known for its commitment to quality and safety in all its products.

Company Profile

As a leader in the field of biotechnology, Bharat Biotech continues to drive innovation and make a positive impact on public health.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326